Patent ID: 7906112
Filing Date: 2011-03-15
Classification: A23K,A23L,A23Y,A61K,A61P,C12N,C12R,Y10S

Abstract:
1. A method of treating diarrhoea in a canine comprising orally administering to the canine a therapeutically effective amount of a composition comprising a biologically pure culture of a strain of lactic acid bacteria selected from the group consisting of Lactobacillus murinus NCIMB 41194, Lactobacillus murinus NCIMB 41195, Lactobacillus murinus NCIMB 41196 and Lactobacillus murinus NCIMB 41197 isolated from resected and washed canine gastrointestinal tract, to treat diarrhoea in the canine; wherein the strain has probiotic activity and has the ability to survive and colonize the gastrointestinal tract of the canine and is able to maintain viability following 1 hour at pH 2.5.